EA201500181A1 - Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни - Google Patents
Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезниInfo
- Publication number
- EA201500181A1 EA201500181A1 EA201500181A EA201500181A EA201500181A1 EA 201500181 A1 EA201500181 A1 EA 201500181A1 EA 201500181 A EA201500181 A EA 201500181A EA 201500181 A EA201500181 A EA 201500181A EA 201500181 A1 EA201500181 A1 EA 201500181A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- pharmaceutical composition
- reflux disease
- gastroesophageal reflux
- ipp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к медицине и фармакологии, а именно к лекарственным средствам - фармацевтическим композициям (фармкомпозиция) для лечения гастроэзофагеальной рефлюксной болезни (ГЭРБ). Фармацевтическая композиция для лечения ГЭРБ, содержит в составе по меньшей мере один ингибитор протонной помпы (ИПП) и по меньшей мере один пребиотик. Заявлен также способ лечения гастроэзофагеальной рефлюксной болезни, при котором наличие Н. pylori не требует проведения эрадикации для предотвращения рисков, связанных с транслокацией бактерии из антрального отдела в тело желудка. Композиция обеспечивает предотвращение транслокации Н.pylori за счет колонизации антрального отдела желудка лактобациллами и конкурентного ингибирования Н.pylori при лечении ИПП, что позволяет отказаться от необходимости в выявлении бактерии и в проведении антибактериального курса эрадикации. Увеличивается безопасность длительной терапии ИПП. При этом не происходит атрофии слизистой оболочки желудка, и как следствие, не увеличивается риск развития рака желудка.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2012137067/15A RU2501549C1 (ru) | 2012-08-30 | 2012-08-30 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
PCT/RU2013/000738 WO2014035295A1 (ru) | 2012-08-30 | 2013-08-22 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201500181A1 true EA201500181A1 (ru) | 2015-05-29 |
Family
ID=49785069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201500181A EA201500181A1 (ru) | 2012-08-30 | 2013-08-22 | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
Country Status (10)
Country | Link |
---|---|
US (1) | US9713610B2 (ru) |
EP (1) | EP2891483A4 (ru) |
JP (1) | JP2015526512A (ru) |
CN (1) | CN104602671A (ru) |
CA (1) | CA2891457A1 (ru) |
EA (1) | EA201500181A1 (ru) |
IN (1) | IN2015DN01160A (ru) |
PH (1) | PH12015500351A1 (ru) |
RU (1) | RU2501549C1 (ru) |
WO (1) | WO2014035295A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
CN108159059A (zh) * | 2017-12-15 | 2018-06-15 | 哈尔滨珍宝制药有限公司 | 一种包含埃索美拉唑钠的药物组合物及其制备方法 |
RU2695067C1 (ru) * | 2019-04-30 | 2019-07-19 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Способ лечения дуоденогастроэзофагеального рефлюкса |
US20220409646A1 (en) * | 2021-06-09 | 2022-12-29 | Isothrive Inc. | Maltosyl-isomalto-oligosaccharides reduce symptoms of gastroesophageal reflux disease |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4993893A (en) | 1992-07-31 | 1994-03-03 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE510666C2 (sv) | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
EP1056456A4 (en) * | 1998-01-30 | 2006-10-25 | Sepracor Inc | R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR |
CA2332774A1 (en) | 1998-05-15 | 1999-11-25 | Dov Michaeli | Method for the treatment of gastroesophageal reflux disease |
UA72748C2 (en) | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
AU2002366796A1 (en) | 2001-12-19 | 2003-07-09 | Eisai Co. Ltd | Methods using proton pump inhibitors |
US7507746B2 (en) * | 2003-02-24 | 2009-03-24 | Mitsubishi Pharma Corporation | Enantiomer of tenatoprazole and the use thereof in therapy |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
AU2004287485A1 (en) * | 2003-11-05 | 2005-05-19 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
JP2007522217A (ja) * | 2004-02-10 | 2007-08-09 | サンタラス インコーポレイティッド | プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ |
US20060165824A1 (en) | 2005-01-26 | 2006-07-27 | The Procter & Gamble Company | Compositions, kits, and methods for enhancing gastrointestinal health |
EA200802038A1 (ru) * | 2006-04-10 | 2009-06-30 | Александр Владимирович ДИКОВСКИЙ | Фармацевтическая композиция энтеросорбента и пребиотиков, лекарственные формы и способ профилактики и лечения заболеваний желудочно-кишечного тракта |
CN101317604B (zh) * | 2008-07-09 | 2011-07-20 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种添加益生元适合孕妇饮用的液态奶 |
EP2208500A1 (en) | 2009-01-16 | 2010-07-21 | Bionap S.r.L. | Compositions for the treatment of gerd (gastroesophageal reflux disease) |
RU2410100C2 (ru) * | 2009-03-30 | 2011-01-27 | Александр Владимирович Диковский | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки |
-
2012
- 2012-08-30 RU RU2012137067/15A patent/RU2501549C1/ru active IP Right Revival
-
2013
- 2013-08-22 EA EA201500181A patent/EA201500181A1/ru unknown
- 2013-08-22 EP EP13832613.7A patent/EP2891483A4/en not_active Withdrawn
- 2013-08-22 JP JP2015529748A patent/JP2015526512A/ja active Pending
- 2013-08-22 CA CA2891457A patent/CA2891457A1/en not_active Abandoned
- 2013-08-22 WO PCT/RU2013/000738 patent/WO2014035295A1/ru active Application Filing
- 2013-08-22 CN CN201380042948.7A patent/CN104602671A/zh active Pending
- 2013-08-22 US US14/422,447 patent/US9713610B2/en active Active
-
2015
- 2015-02-12 IN IN1160DEN2015 patent/IN2015DN01160A/en unknown
- 2015-02-18 PH PH12015500351A patent/PH12015500351A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2501549C1 (ru) | 2013-12-20 |
US9713610B2 (en) | 2017-07-25 |
CN104602671A (zh) | 2015-05-06 |
PH12015500351A1 (en) | 2015-04-20 |
CA2891457A1 (en) | 2014-03-06 |
US20150202192A1 (en) | 2015-07-23 |
EP2891483A4 (en) | 2016-05-04 |
JP2015526512A (ja) | 2015-09-10 |
IN2015DN01160A (ru) | 2015-06-26 |
EP2891483A1 (en) | 2015-07-08 |
WO2014035295A1 (ru) | 2014-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891248A1 (ru) | Пролекарства jak-ингибирующего соединения для лечения воспалительного заболевания желудочно-кишечного тракта | |
EA201170349A1 (ru) | Модуляторы mif | |
EA201691354A1 (ru) | Терапевтические ингибирующие соединения | |
BR112014009993A2 (pt) | método para o tratamento de tumores do estroma gastrointestinal | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
BR112013021236A2 (pt) | composto, composição,e, método de tratamento de um distúrbio, uma condição ou uma doença | |
EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
EA201290184A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
BR112015000349A2 (pt) | método de tratamento de tumores estromais gastrointestinais | |
BR112015009168A2 (pt) | composto de fórmula estrutural xi, uso de um composto, composição farmacêutica, método de tratamento de uma doença mediada pela pde4 em um sujeito, método de modulação de uma função mediada pela pde4 em um sujeito, método de alcançar um efeito em um paciente e método para inibir a pde4 | |
EA201290919A1 (ru) | Индазольные соединения и их применение | |
BR112012019762A2 (pt) | composto, composição, e, método para tratar uma doença. | |
EA201291099A1 (ru) | Новые иммуномодуляторные и противовоспалительные соединения | |
EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201791451A1 (ru) | 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита | |
EA201391720A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
EA201101477A1 (ru) | Органические соединения и их применение | |
EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201500996A1 (ru) | Терапевтические применения эмпаглифлозина | |
EA201590703A1 (ru) | Ингибиторы mek при лечении вирусных заболеваний | |
BR112018069147A2 (pt) | composto da fórmula iii, composição farmacêutica, método de inibição da função de fimh e método de tratamento de uma doença mediada por fimh | |
MX2018004043A (es) | Prevencion, tratamiento y reversion de enfermedad usando cantidades terapeuticamente efectivas de acidos grasos activados. | |
EA201492279A1 (ru) | Лекарственное средство для предупреждения и/или лечения поликистозной болезни почек | |
EA201101686A1 (ru) | Новые композиции для лечения шмт и связанных с ней расстройств |